Image (Stribild 01)
Stribild Tablet, Film Coated
Product Images NDC 61958-1201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Stribild (NDC 61958-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Stribild 02)
Chemical Structure (Stribild 03)
Chemical Structure (Stribild 04)
Chemical Structure (Stribild 05)
Principal Display Panel (30 Tablet Bottle Label)
Stribild 07
Stribild tablets are a combination of several active ingredients including 150mg of elvitegravir, 200mg of emtricitabine, and 300mg of tenofovir disoproxil. They are available in a package containing 30 tablets and are designed to be used in the treatment of certain types of viruses. The pack contains an ALERT box, and the pharmacist is advised not to cover it with the pharmacy label. The medication is manufactured by Gilead Sciences in Canada and should be kept in its original container. Dosage instructions are also provided, and caution is given to keep it out of reach of children.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
